Press releases

Focus on the long-term consequences of infections

International Symposium of the Leibniz Centre Infection

The emergence of Long COVID has raised awareness of the long-term consequences of infections. However, other infections can also have long-term consequences, even if the pathogen has been successfully combated. As part of the 13th LCI Symposium "Long-term Consequences of Infections" organised by the Leibniz Centre Infection (LCI) research network in northern Germany, international scientists will come together to discuss the long-term effects of infectious diseases. The event will take place on 1 and 2 February 2024 at the Bernhard Nocht Institute for Tropical Medicine in Hamburg.

[Translate to English:] Der historische Hörsaal während ein Vortrag gehalten wird.
©BNITM | Dino Schachten

The long-term consequences of an infection can have significant consequences for the health and quality of life of those affected. Medical research is increasingly focussing not only on the acute stage of infection, but also on the post-infection phase. Long-term consequences can be diverse and range from persistent symptoms to health complications, as well as social and economic problems.

 

Invitation for members of the press:

Representatives of the press are cordially invited to attend the symposium. There will be an opportunity for separate questions and discussions with selected speakers and the current LCI spokesperson Prof Ulrich E. Schaible.

Press conferences on 1 and 2 February 2024 by appointment.

Registration: presse@leibniz-liv.de, Tel.: 040/48051-108.

 

In post-COVID, fatigue (pathological exhaustion) and exercise intolerance are the most common symptoms. "We have also discovered that some of those affected by SARS-CoV-2 infection develop myalgic encephalomyelitis / chronic fatigue syndrome, or ME/CFS for short - a severe, complex and usually chronic disease due to dysregulation of the central and autonomic nervous system, the immune system and the metabolism," explains Prof Carmen Scheibenbogen, Head of the Immunodeficiency Outpatient Clinic at Charité Berlin and invited speaker. ME/CFS is not only triggered by coronaviruses, but also other viruses. According to cross-sectional data from various studies from 2011 to 2020, 150,000 to 300,000 people in Germany already had the disease before the pandemic, writes the Institute for Quality and Efficiency in Healthcare in its final report 2023. "But the disease was hardly recognised and therefore there was hardly any research funding," says Scheibenbogen.

Prof Gülşah Gabriel, head of the Viral Zoonoses - One Health department at the Leibniz Institute of Virology (LIV), is also investigating the possible long-term consequences of COVID-19 disease. In particular, current research is focussing on sex hormones, which can influence the gender-dependent severity of the disease. She emphasises: "The influence of respiratory viral infections on the endocrine system with possible long-term consequences is a new field of research that requires special attention."

Bacterial infectious diseases, such as tuberculosis, can also have long-term consequences. Researchers at the Research Centre Borstel (FZB) are investigating the long-term consequences of tuberculosis in the BMBF-Africa-funded TB-Sequel II network under the leadership of LMU Munich together with partners in four African countries. Prof Andrea Rachow from the LMU Munich and spokesperson of the TB-Sequel II network will give a lecture on this topic.

Research in a holistic context

The diverse programme of the event will highlight the long-term consequences of infections on the immune system, on the affected organs and on the socio-economic situation of those affected in three thematic blocks.

In the session on the socio-economic consequences of an infection, scientists such as Prof César Muñoz-Fontela, Head of the Virus Immunology Working Group at the Bernhard Nocht Institute for Tropical Medicine (BNITM), will discuss how misguided communication or disinformation campaigns have exacerbated epidemics in the past. "Global warming, the need to feed the world and political messages are factors that have a major impact on the occurrence of zoonotic viral infections," emphasises Muñoz-Fontela.

"It is our goal as LCI to investigate the dynamics of infections and to find out why long-term consequences arise in some patients in order to develop innovative strategies to deal with the long-term consequences," says LCI spokesperson and Director at the FZB, Prof Ulrich Schaible. This symposium marks a further step towards a comprehensive understanding and more effective measures in dealing with infectious diseases worldwide.

Highlights of the symposium include presentations by renowned scientists:

Prof. Dr. Tobias Welte from the Hannover Medical School will discuss how viral infections can worsen the course and symptoms of chronic cardiovascular and respiratory diseases and the role of vaccinations as the most important preventive measure.

Dr. Tom Wingfield from the Liverpool School of Tropical Medicine discusses the social dimensions of tuberculosis and shows how preventive measures and care strategies can be organised more effectively.

Prof Dr. Cecilie Svanes from the University of Bergen will speak about the prenatal origins of respiratory diseases and the role infections play in this.

Prof. Dr. Susanne Nylén from the Karolinska Institute in Stockholm presents her research on the interaction of parasites with the host. Her focus is on how intestinal nematodes shape the immune landscape in the long term and what impact this has on infections and vaccinations.

The FZB has also invited a special guest from Cape Town - Dr Zolelwa Sifumba, a doctor and former tuberculosis patient, who is an activist with the NGO TB Proof and will talk about her experiences with the disease and its long-term effects in her contribution "Tuberculosis and me".


About the Leibniz Center Infection:

The Leibniz Center Infection (LCI) is a dynamic alliance of the Leibniz Institutes Bernhard Nocht Institute for Tropical Medicine (BNITM), Research Centre Borstel, Leibniz Lung Centre (FZB) and the Leibniz Institute of Virology (LIV). As members of the Leibniz Association, the institutes conduct strategic, topic-orientated research into scientific issues of social relevance. The main purpose of the alliance is to promote the research focus on Global and Emerging Infections as a core competence in the North German scientific area. The aim is to create a national centre of excellence in infection research together with local university partners and major research institutions.

Further informationen www.lc-infection.de.

Press contact LCI

Julia Häberlein 
Tel.: 040/48051-108

presse@leibniz-liv.de

Organisation office

Dr Susanne Pätzold

Tel.: 04537/188-5840

spaetzold@fz-borstel.de

Contact person